Afya Limited (NASDAQ:AFYA – Get Free Report) was the recipient of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 869,400 shares, a growth of 34.5% from the March 15th total of 646,200 shares. Approximately 4.8% of the company’s shares are sold short. Based on an average daily trading volume, of 132,000 shares, the short-interest ratio is presently 6.6 days.
Institutional Investors Weigh In On Afya
Hedge funds have recently added to or reduced their stakes in the stock. Mirabella Financial Services LLP bought a new stake in Afya in the third quarter worth $1,686,000. HBK Sorce Advisory LLC boosted its holdings in Afya by 10.0% in the fourth quarter. HBK Sorce Advisory LLC now owns 11,044 shares of the company’s stock worth $242,000 after acquiring an additional 1,000 shares in the last quarter. Raymond James Financial Services Advisors Inc. bought a new stake in Afya in the third quarter worth $183,000. Daiwa Securities Group Inc. lifted its holdings in shares of Afya by 32.6% during the third quarter. Daiwa Securities Group Inc. now owns 4,145 shares of the company’s stock valued at $65,000 after purchasing an additional 1,020 shares in the last quarter. Finally, Quantbot Technologies LP bought a new position in shares of Afya during the third quarter valued at $118,000. 88.02% of the stock is owned by institutional investors.
Afya Price Performance
Shares of AFYA stock opened at $16.96 on Friday. The stock has a market cap of $1.59 billion, a price-to-earnings ratio of 19.72, a PEG ratio of 0.56 and a beta of 0.97. The business’s fifty day moving average is $19.81 and its 200 day moving average is $19.30. Afya has a twelve month low of $10.72 and a twelve month high of $22.48. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.45.
Analyst Upgrades and Downgrades
AFYA has been the topic of several recent research reports. Citigroup initiated coverage on Afya in a research note on Monday, January 29th. They issued a “neutral” rating and a $23.00 price target on the stock. Morgan Stanley cut Afya from an “overweight” rating to an “equal weight” rating and upped their price target for the stock from $20.50 to $23.00 in a research note on Monday, January 22nd.
View Our Latest Research Report on Afya
Afya Company Profile
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Articles
- Five stocks we like better than Afya
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 5 Trends You Need to Know This Quarter
- 3 Grocery Stocks That Are Proving They Are Still Essential
- MarketBeat Week in Review – 4/8 – 4/12
- What is a Death Cross in Stocks?
- You Can Follow BlackRock’s Market View for Your Money
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.